Evidence-based psychological and pharmacological interventions for perinatal mood and anxiety disorders
Presented by Ajeng Puspitasari, PhD, LP, ABPP, and Hemalatha Rajanna, MD
View slides from this presentation
Perinatal mood and anxiety disorder (PMAD) is not only debilitating for women during pregnancy and the first 12 months postpartum, but can lead to socioeconomic burden, suicidal behaviors, and negative impacts on children and partners. Though evidence-based treatments exist, up to 86% of women experiencing PMAD do not receive the treatment they need. In this webinar, learn how to reduce barriers to treatment and increase access to care.
Related resources
Jessica says from the time her son, Jake, was little, her family’s life…
Rogers experts discuss healthy ways to manage stress and how that improves…
Jana’s story: How Rogers’ OCD and anxiety treatment helped her pursue her Miss America pageant dream
While growing up, Jana enjoyed being in the spotlight. She participated in…